메뉴 건너뛰기




Volumn 18, Issue 9, 2016, Pages 907-915

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

(16)  Khunti, K a   Alsifri, S b   Aronson, R c   Cigrovski Berkovic M d   Enters Weijnen, C e   Forsen T f   Galstyan, G g   Geelhoed Duijvestijn, P h   Goldfracht, M i,j   Gydesen, H k   Kapur, R k   Lalic, N l   Ludvik, B m   Moberg, E n   Pedersen Bjergaard, U o   Ramachandran, A p  


Author keywords

diabetes; global; HAT study; hypoglycaemia; insulin; observational

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

EID: 84977080761     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12689     Document Type: Article
Times cited : (204)

References (27)
  • 1
    • 84893426320 scopus 로고    scopus 로고
    • Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals
    • Leiter LA, Boras D, Woo VC. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals. Can J Diabetes 2014; 38: 38–44.
    • (2014) Can J Diabetes , vol.38 , pp. 38-44
    • Leiter, L.A.1    Boras, D.2    Woo, V.C.3
  • 2
    • 84866268783 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    • Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364–1379.
    • (2012) Diabetes Care , vol.35 , pp. 1364-1379
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 3
    • 84903552407 scopus 로고    scopus 로고
    • Type 1 diabetes through the life span: a position statement of the American Diabetes Association
    • Chiang JL, Kirkman MS, Laffel LM, Peters AL, Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 2014; 37: 2034–2054.
    • (2014) Diabetes Care , vol.37 , pp. 2034-2054
    • Chiang, J.L.1    Kirkman, M.S.2    Laffel, L.M.3    Peters, A.L.4
  • 4
    • 34547830134 scopus 로고    scopus 로고
    • Long-acting insulin analogs vs. NPH insulin (human isophane insulin) for type 2 diabetes mellitus
    • Apr 18
    • Horvath K, Jeitler K, Berghold A et al. Long-acting insulin analogs vs. NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007: Apr 18;(2):CD005613.
    • (2007) Cochrane Database Syst Rev , Issue.2 , pp. CD005613
    • Horvath, K.1    Jeitler, K.2    Berghold, A.3
  • 9
    • 84890313541 scopus 로고    scopus 로고
    • Understanding the economic burden of non-severe nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization
    • Brod M, Wolden M, Christensen T, Bushnell DM. Understanding the economic burden of non-severe nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Health 2013; 16: 1140–1149.
    • (2013) Value Health , vol.16 , pp. 1140-1149
    • Brod, M.1    Wolden, M.2    Christensen, T.3    Bushnell, D.M.4
  • 10
    • 84889805578 scopus 로고    scopus 로고
    • Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and well-being in insulin-treated patients with diabetes in seven European countries
    • Geelhoed-Duijvestijn PH, Pedersen-Bjergaard U, Weitgasser R, Lahtela J, Jensen MM, Ostenson CG. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and well-being in insulin-treated patients with diabetes in seven European countries. J Med Econ 2013; 16: 1453–1461.
    • (2013) J Med Econ , vol.16 , pp. 1453-1461
    • Geelhoed-Duijvestijn, P.H.1    Pedersen-Bjergaard, U.2    Weitgasser, R.3    Lahtela, J.4    Jensen, M.M.5    Ostenson, C.G.6
  • 12
    • 33947704161 scopus 로고    scopus 로고
    • PREDICTIVE – a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycemia from the European cohort
    • Luddeke HJ, Sreenan S, Aczel S et al. PREDICTIVE – a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycemia from the European cohort. Diabetes Obes Metab 2007; 9: 428–434.
    • (2007) Diabetes Obes Metab , vol.9 , pp. 428-434
    • Luddeke, H.J.1    Sreenan, S.2    Aczel, S.3
  • 13
    • 84901235805 scopus 로고    scopus 로고
    • Incidence, worry and discussion about dosing irregularities and self-treated hypoglycemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey
    • Munro N, Barnett AH. Incidence, worry and discussion about dosing irregularities and self-treated hypoglycemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. Int J Clin Pract 2014; 68: 692–699.
    • (2014) Int J Clin Pract , vol.68 , pp. 692-699
    • Munro, N.1    Barnett, A.H.2
  • 14
    • 18144388647 scopus 로고    scopus 로고
    • Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia
    • Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245–1249.
    • (2005) Diabetes Care , vol.28 , pp. 1245-1249
  • 15
    • 84873248938 scopus 로고    scopus 로고
    • The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
    • Khunti K, Caputo S, Damci T et al. The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. Diabetes Obes Metab 2012; 14: 1129–1136.
    • (2012) Diabetes Obes Metab , vol.14 , pp. 1129-1136
    • Khunti, K.1    Caputo, S.2    Damci, T.3
  • 16
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–139.
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 17
    • 74949138626 scopus 로고    scopus 로고
    • The effects of baseline characteristics, glycaemia treatment approach, and glycated hemoglobin concentration on the risk of severe hypoglycemia: post-hoc epidemiological analysis of the ACCORD study
    • Miller ME, Bonds DE, Gerstein HC et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated hemoglobin concentration on the risk of severe hypoglycemia: post-hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: b5444.
    • (2010) BMJ , vol.340 , pp. b5444
    • Miller, M.E.1    Bonds, D.E.2    Gerstein, H.C.3
  • 18
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–2572.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
    • Patel, A.1    MacMahon, S.2    Chalmers, J.3
  • 19
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 20
    • 20444408424 scopus 로고    scopus 로고
    • Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population-based study
    • Donnelly LA, Morris AD, Frier BM et al. Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749–755.
    • (2005) Diabet Med , vol.22 , pp. 749-755
    • Donnelly, L.A.1    Morris, A.D.2    Frier, B.M.3
  • 21
    • 84926670200 scopus 로고    scopus 로고
    • Frequency and predictors of confirmed hypoglycemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study
    • Cariou B, Fontaine P, Eschwege E et al. Frequency and predictors of confirmed hypoglycemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metab 2015; 41: 116–125.
    • (2015) Diabetes Metab , vol.41 , pp. 116-125
    • Cariou, B.1    Fontaine, P.2    Eschwege, E.3
  • 22
    • 34247871323 scopus 로고    scopus 로고
    • Risk of hypoglycemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
    • UK Hypoglycemia Study Group. Risk of hypoglycemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140–1147.
    • (2007) Diabetologia , vol.50 , pp. 1140-1147
  • 23
    • 84935511058 scopus 로고    scopus 로고
    • Prevalence and incidence of hypoglycemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies
    • Edridge C, Dunkley A, Bodicoate D et al. Prevalence and incidence of hypoglycemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One 2015; 10: e0126427.
    • (2015) PLoS One , vol.10
    • Edridge, C.1    Dunkley, A.2    Bodicoate, D.3
  • 24
    • 85032499505 scopus 로고    scopus 로고
    • Health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes
    • Content presented in poster at EASD 2015
    • Elliot L, Aronson R, Galstyan G et al. Health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. Diabetologia 2015; 58(Suppl. 1): S480 (Abstract 991). Content presented in poster at EASD 2015.
    • (2015) Diabetologia , vol.58 , pp. S480
    • Elliot, L.1    Aronson, R.2    Galstyan, G.3
  • 25
    • 84908352320 scopus 로고    scopus 로고
    • Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012
    • Karges B, Rosenbauer J, Kapellen T et al. Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med 2014; 11: e1001742.
    • (2014) PLoS Med , vol.11
    • Karges, B.1    Rosenbauer, J.2    Kapellen, T.3
  • 26
    • 0036314189 scopus 로고    scopus 로고
    • Hypoglycemia-associated autonomic failure in advanced type 2 diabetes
    • Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51: 724–733.
    • (2002) Diabetes , vol.51 , pp. 724-733
    • Segel, S.A.1    Paramore, D.S.2    Cryer, P.E.3
  • 27
    • 33644664033 scopus 로고    scopus 로고
    • Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes
    • Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54: 3592–3601.
    • (2005) Diabetes , vol.54 , pp. 3592-3601
    • Cryer, P.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.